Core Viewpoint - Sanxin Medical (300453) is enhancing its product portfolio around various blood purification treatment models and is focusing on the iterative upgrade of hemodialysis products while expanding into diabetes, early to mid-stage kidney disease, and vascular intervention fields [1] Group 1: Product Development and Innovation - The company is developing innovative medical devices and high-value consumables to replace imports, including artificial blood vessels, anticoagulant-coated catheters, plasma separators, and blood loss monitors [1] - Several projects under research and development have received support from Jiangxi Province's key research and development plan, Ganpo Talent Support Plan, and major provincial and municipal science and technology projects [1] Group 2: Clinical Trials and Progress - The artificial blood vessel project, which is primarily aimed at hemodialysis treatment, is currently in multi-center clinical trials and has achieved significant progress [1]